1. Home
  2. IPGP vs MLTX Comparison

IPGP vs MLTX Comparison

Compare IPGP & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPGP
  • MLTX
  • Stock Information
  • Founded
  • IPGP 1990
  • MLTX 2021
  • Country
  • IPGP United States
  • MLTX Switzerland
  • Employees
  • IPGP N/A
  • MLTX N/A
  • Industry
  • IPGP Semiconductors
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPGP Technology
  • MLTX Health Care
  • Exchange
  • IPGP Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • IPGP 3.0B
  • MLTX 2.8B
  • IPO Year
  • IPGP 2006
  • MLTX N/A
  • Fundamental
  • Price
  • IPGP $75.22
  • MLTX $52.92
  • Analyst Decision
  • IPGP Buy
  • MLTX Strong Buy
  • Analyst Count
  • IPGP 7
  • MLTX 7
  • Target Price
  • IPGP $72.75
  • MLTX $73.33
  • AVG Volume (30 Days)
  • IPGP 196.3K
  • MLTX 532.6K
  • Earning Date
  • IPGP 08-05-2025
  • MLTX 08-11-2025
  • Dividend Yield
  • IPGP N/A
  • MLTX N/A
  • EPS Growth
  • IPGP N/A
  • MLTX N/A
  • EPS
  • IPGP N/A
  • MLTX N/A
  • Revenue
  • IPGP $952,918,000.00
  • MLTX N/A
  • Revenue This Year
  • IPGP N/A
  • MLTX N/A
  • Revenue Next Year
  • IPGP $7.66
  • MLTX N/A
  • P/E Ratio
  • IPGP N/A
  • MLTX N/A
  • Revenue Growth
  • IPGP N/A
  • MLTX N/A
  • 52 Week Low
  • IPGP $48.59
  • MLTX $31.42
  • 52 Week High
  • IPGP $88.50
  • MLTX $58.26
  • Technical
  • Relative Strength Index (RSI)
  • IPGP 54.20
  • MLTX 57.74
  • Support Level
  • IPGP $75.14
  • MLTX $46.12
  • Resistance Level
  • IPGP $81.09
  • MLTX $55.91
  • Average True Range (ATR)
  • IPGP 2.24
  • MLTX 2.45
  • MACD
  • IPGP -0.27
  • MLTX -0.46
  • Stochastic Oscillator
  • IPGP 38.21
  • MLTX 60.02

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: